These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6992903)

  • 1. Clinical and pharmacokinetic factors affecting response to phenelzine.
    Tyrer P; Gardner M; Lambourn J; Whitford M
    Br J Psychiatry; 1980 Apr; 136():359-65. PubMed ID: 6992903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical trial of phenelzine in anxiety depressive and phobic neuroses.
    Mountjoy CQ; Roth M; Garside RF; Leitch IM
    Br J Psychiatry; 1977 Nov; 131():486-92. PubMed ID: 338081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacology of phenelzine.
    Robinson DS; Nies A; Ravaris CL; Ives JO; Bartlett D
    Arch Gen Psychiatry; 1978 May; 35(5):629-35. PubMed ID: 365127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multiple-dose, controlled study of phenelzine in depression-anxiety states.
    Ravaris CL; Nies A; Robinson DS; Ives JO; Lamborn KR; Korson L
    Arch Gen Psychiatry; 1976 Mar; 33(3):347-50. PubMed ID: 769725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of acetylator phenotype on antidepressant effects of phenelzine.
    Paykel ES; West PS; Rowan PR; Parker RR
    Br J Psychiatry; 1982 Sep; 141():243-8. PubMed ID: 6753997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical effects of abrupt withdrawal from tri-cyclic antidepressants and monoamine oxidase inhibitors after long-term treatment.
    Tyrer P
    J Affect Disord; 1984 Feb; 6(1):1-7. PubMed ID: 6231324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the clinical effects of phenelzine and placebo in the treatment of phobic anxiety.
    Tyrer P; Candy J; Kelly D
    Psychopharmacologia; 1973 Sep; 32(3):237-54. PubMed ID: 4586902
    [No Abstract]   [Full Text] [Related]  

  • 8. Acetylator status and response to phenelzine.
    Tyrer P; Gardner M
    Lancet; 1978 Nov; 2(8097):994-5. PubMed ID: 82019
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship between neurosis and personality disorder.
    Tyrer P; Casey P; Gall J
    Br J Psychiatry; 1983 Apr; 142():404-8. PubMed ID: 6342698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of acetylator phenotype on the outcome of treatment with phenelzine, in a clinical trial.
    Marshall EF; Mountjoy CQ; Campbell IC; Garside RF; Leitch IM; Roth M
    Br J Clin Pharmacol; 1978 Sep; 6(3):247-54. PubMed ID: 356868
    [No Abstract]   [Full Text] [Related]  

  • 11. Are monoamine-oxidase inhibitors antidepressants?
    Tyrer TP
    Proc R Soc Med; 1973 Sep; 66(9):950-1. PubMed ID: 4805106
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of platelet monoamine oxidase in depressed subjects treated with phenelzine.
    Davidson J; McLeod MN; White HL
    Am J Psychiatry; 1978 Apr; 135(4):470-2. PubMed ID: 345826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind trial of phenelzine and amitriptyline in depressed out-patients. A possible differential effect of the drugs on symptoms.
    Kay DW; Garside RF; Fahy TJ
    Br J Psychiatry; 1973 Jul; 123(572):63-7. PubMed ID: 4580991
    [No Abstract]   [Full Text] [Related]  

  • 14. Phenelzine and atenolol in social phobia.
    Liebowitz MR; Schneier F; Campeas R; Gorman J; Fyer A; Hollander E; Hatterer J; Papp L
    Psychopharmacol Bull; 1990; 26(1):123-5. PubMed ID: 2196620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenelzine and amitriptyline: effects on symptoms of neurotic depression.
    Rowan PR; Paykel ES; Parker RR
    Br J Psychiatry; 1982 May; 140():475-83. PubMed ID: 7049292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy of four men with paruresis.
    Hatterer JA; Gorman JM; Fyer AJ; Campeas RB; Schneier FR; Hollander E; Papp LA; Liebowitz MR
    Am J Psychiatry; 1990 Jan; 147(1):109-11. PubMed ID: 2403470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic response to phenelzine in patients with panic disorder and agoraphobia with panic attacks.
    Buigues J; Vallejo J
    J Clin Psychiatry; 1987 Feb; 48(2):55-9. PubMed ID: 3542985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study.
    Robinson DS; Lerfald SC; Bennett B; Laux D; Devereaux E; Kayser A; Corcella J; Albright D
    Psychopharmacol Bull; 1991; 27(1):31-9. PubMed ID: 1862204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenelzine and exposure in the treatment of phobias.
    Solyom C; Solyom L; LaPierre Y; Pecknold J; Morton L
    Biol Psychiatry; 1981 Mar; 16(3):239-47. PubMed ID: 6112024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting the delay of antidepressant effect in responders to nortriptyline and phenelzine.
    Georgotas A; McCue RE; Cooper TB; Nagachandran N; Friedhoff A
    Psychiatry Res; 1989 Apr; 28(1):1-9. PubMed ID: 2662234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.